PC
Paul Choi Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
2.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
40%
Neutral
40%
Negative
20%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $12 |
26%
upside
| 2 | – |
–
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $95 |
125%
upside
| 1 | -17% |
0
%
| 19 Dec ‘25 4 months ago |
|
|
|
Buy
Upgraded
| $95 |
42%
upside
| 1 | -4.4% |
0
%
| 19 Dec ‘25 4 months ago |
|
|
|
Sell
Maintained
| $50 |
31%
downside
| 1 | +1.6% |
0
%
| 5 Nov ‘25 5 months ago |
|
|
|
Buy
Maintained
| $100 |
30%
upside
| 1 | +12% |
0
%
| 31 Oct ‘25 5 months ago |
|
|
|
Buy
Maintained
| $55 |
22%
upside
| 1 | +21% |
0
%
| 29 Oct ‘25 5 months ago |
|
|
|
Sell
Downgraded
| $6 |
45%
downside
| 3 | -32% |
0
%
| 15 Oct ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $77 |
8%
downside
| 1 | -44% |
–
| 8 Oct ‘25 6 months ago |
|
|
|
Neutral
Initiated
| $20 |
42%
downside
| 1 | – |
–
| 25 Sep ‘25 6 months ago |
|
|
|
Buy
Initiated
| $47 |
5%
upside
| 1 | +5% |
0
%
| 17 Sep ‘25 7 months ago |
|
|
|
Sell
Maintained
| $12 |
20%
downside
| 2 | -34% |
0
%
| 25 Jun ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $3 |
87%
downside
| 2 | – |
–
| 22 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $8 |
1,694%
upside
| 2 | -15% |
0
%
| 16 May ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $5 |
62%
downside
| 2 | – |
–
| 2 May ‘25 11 months ago |
|